- Filed
- Dec 10, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Dec 4, 2024 | 92.28M sh |
| Cash And Equivalents | Q3 2024 · Jan 31, 2024 | $178.32M |
| Cash And Equivalents | Q3 2024 · Oct 31, 2023 | $206.24M |
| Current Liabilities | Q3 2024 · Jan 31, 2024 | $994.21M |
| Current Liabilities | Q3 2024 · Oct 31, 2023 | $1.05B |
| Total Liabilities | Q3 2024 · Jan 31, 2024 | $2B |
| Total Liabilities | Q3 2024 · Oct 31, 2023 | $2.06B |
| Current Assets | Q3 2024 · Jan 31, 2024 | $1.28B |
| Current Assets | Q3 2024 · Oct 31, 2023 | $1.49B |
| Total Assets | Q3 2024 · Jan 31, 2024 | $4.11B |
| Total Assets | Q3 2024 · Oct 31, 2023 | $4.11B |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 94.45M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 94.17M sh |
| Stock Repurchased | Q3 2024 · Oct 31, 2023 | $0 |
| Capex | Q3 2024 · Oct 31, 2023 | $151.04M |
| Operating Cash Flow | Q3 2024 · Oct 31, 2023 | $280.24M |
| Stockholders Equity | Q3 2024 · Oct 31, 2023 | $2.05B |
| Stockholders Equity | Q3 2024 · Jul 31, 2023 | $1.97B |
| Stockholders Equity | Q3 2024 · Jan 31, 2023 | $1.79B |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | $0.88 |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | $2.55 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | $0.89 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | $2.59 |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $345.43M |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $968.76M |
| Net Income | Q3 2024 · Oct 31, 2023 | $83.01M |
| Net Income | Q3 2024 · Oct 31, 2023 | $239.92M |
| Operating Income | Q3 2024 · Oct 31, 2023 | $108.98M |
| Operating Income | Q3 2024 · Oct 31, 2023 | $312.46M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $454.41M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $1.28B |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $825.38M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $2.38B |
| Revenue | Q3 2024 · Oct 31, 2023 | $1.28B |
| Revenue | Q3 2024 · Oct 31, 2023 | $3.67B |